CLS: New Trial Initiated in the Netherlands - Redeye
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Aktieanalys

CLS: New Trial Initiated in the Netherlands - Redeye

{newsItem.title}

Redeye is encouraged to learn that Radboud University Medical Center in Nijmegen, the Netherlands, has initiated an Investigator Initiated Trial (IIT) to evaluate MR-guided FLA in localized prostate cancer using the TRANBERG Thermal Therapy System with Thermoguide Workstation. We continue to see an interesting 2022 ahead and reiterate our Base Case.

Länk till analysen i sin helhet: https://www.redeye.se/research/833910/cls-new-trial-initiated-in-the-netherlands?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt